OSU Professor Falsified Data on Eight Papers, Resigns

Ching-Shih Chen’s research involved anticancer therapeutics that were being tested in clinical trials.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, NHEYOBCancer researcher Ching-Shih Chen of the Ohio State University (OSU) resigned last September after a university investigation found him guilty of scientific misconduct on eight papers, according to a statement released by OSU on Friday (March 30). In a 75-page redacted report also made public on Friday, university investigators conclude that the former professor, whose work centered on the development of anticancer therapeutics, falsified data on at least 14 occasions in the last 12 years.

The investigation into Chen’s work was launched in 2016 after OSU received anonymous allegations of six instances of data falsification in papers published between 2010 and 2014, according to OSU student newspaper, The Lantern. Seizure of Chen’s hard drive led to the discovery of multiple manipulated images, and helped take the number of allegations up to 21.

In eight papers, “Dr. Chen committed Research Misconduct by deviating from the accepted practices of image handling and figure generation and intentionally falsified data,” a three-person committee concluded in the report. In another paper, he was found to have acted “‘recklessly’ by not reviewing or scrutinizing the data provided to him leading to the inappropriate reuse of data.”

C.K. Gunsalus, director of the National Center for Professional and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours